Pieris Pharmaceuticals, Inc. (PIRS) Social Stream
Pieris Pharmaceuticals Inc (PIRS) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering Pieris Pharmaceuticals Inc.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
PIRS's average price target has moved down $1 over the prior 46 weeks.
Over the past 46 weeks, PIRS's average upside potential has been 179.77%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
PIRS Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
PIRS's average broker recommendation rating improved by 0.5 over the prior 151 days.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how Pieris Pharmaceuticals Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than 87.5% of that group.
- In the context of Business Services stocks, Pieris Pharmaceuticals Inc's average analyst price target is greater than 9.07% of them.
- In the context of Business Services stocks, Pieris Pharmaceuticals Inc's number of analysts covering the stock is higher than 12.39% of them.
- In terms of how Pieris Pharmaceuticals Inc fares relative to Business Services stocks, note that its upside potential (average analyst target price relative to current price) is higher than 173.08% of that group.
Is PIRS a Buy, Hold or Sell? See the POWR Ratings now!